NN6.DE

NanoRepro AG [NN6.DE] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

NN6.DE Stock Summary

Top 10 Correlated Stocks

NN6.DE

In the News

NN6.DE Financial details

Company Rating
-
Market Cap
23.03M
Income
-2.57M
Revenue
82.63M
Book val./share
-
Cash/share
-
Dividend
0.15
Dividend %
7.28%
Employees
17
Optionable
No
Shortable
Yes
Earnings
30 Jul 2020
P/E
-7.14
Forward P/E
-
PEG
0.66
P/S
0.65
P/B
0.56
P/C
-
P/FCF
2.58
Quick Ratio
36.75
Current Ratio
42.09
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.19
EPS next Y
-
EPS next Q
-
EPS this Y
-112.61%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
53.44%
Revenue last 5Y
69.53%
Revenue Q/Q
-88.9%
EPS Q/Q
-30%
-
-
-
-
SMA20
-5.59%
SMA50
3.85%
SMA100
-11.18%
Inst Own
-
Inst Trans
-
ROA
-8%
ROE
-7%
ROC
0.11%
Gross Margin
31%
Oper. Margin
14%
Profit Margin
-10%
Payout
-173%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.61-2.84
52W High
-29.5%
52W Low
+41%
RSI
56.04
Rel Volume
-
Avg Volume
9.51K
Volume
28
Perf Week
4.44%
Perf Month
10.16%
Perf Quarter
-17.54%
Perf Half Y
-18.97%
-
-
-
-
Beta
-3.056
-
-
Volatility
0.03%, 0.06%
Prev Close
4.44%
Price
1.41
Change
5.22%

NN6.DE Financial Performance

NN6.DE Dividend History

NN6.DE Frequently Asked Questions

What is NanoRepro AG stock symbol ?

NanoRepro AG is a DE stock and trading under the symbol NN6.DE

What is NanoRepro AG stock quote today ?

NanoRepro AG stock price is $1.41 today.

Is NanoRepro AG stock public?

Yes, NanoRepro AG is a publicly traded company.

Something similar

Top by Market Cap
ABEA.DE
BRK-B
DHR-PB
LLY
NVD.DE
Same Sector
ALGS
1783.TW
UNCY
268600.KQ
0512.HK
Top Correlated Stocks
CTH1V.HE
FLOB.BR
DRW8.DE
0255.HK
EAAS.L
Similar Market Cap
MOXC
MEXX
PPS.TO
GFAIW
IGXT

Company Profile

Healthcare Medical - Diagnostics & Research
  • Volume Average 9.51K
  • Market Capitalization 23.03M
  • Employee 17
  • CEO Ms. Lisa Jungst
  • Headquarters Marburg,DE
  • IPO Date 2009-10-22
  • Website https://www.nanorepro.com

NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, including allergy, family planning, and preventive healthcare line products; point of care testing products for hospitals and medical practices for detection of HIV, human cardiac Troponin I, D-dimer, streptococci antigen, influenza type A and B antigens, and microalbumin; and immunochromatographic lateral flow tests for the diagnostic detection of biomarkers, as well as rapid SARS-CoV-2 antibody test and corona antigen rapid test. It also provides food supplements for men and women through online shops, as well as through pharmacies. The company is headquartered in Marburg, Germany.